+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A retrospective study of compliance with recommended hematologic monitoring of carbamazepine



A retrospective study of compliance with recommended hematologic monitoring of carbamazepine



Dicp 24(12): 1166-1168



Early case reports of fatal hematologic effects associated with carbamazepine (CBZ) resulted in manufacturer recommendations for extensive laboratory monitoring. Several alternative monitoring protocols have been published, indicating disagreement with those recommendations. The manufacturers has removed specific monitoring guidelines allowing physicians to monitor CBZ during treatment based on their clinical judgment. This study was designed to determine the frequency of CBZ hematologic monitoring in one academic setting. Data on complete blood counts (CBCs) were retrospectively obtained and were compared with 1975-88 Physicians' Desk Reference recommendations for weekly CBCs during the first three months of treatment. Eighty-three patients were identified: 32 psychiatry, 37 neurology, and 14 from other clinics. Only one patient met guidelines for monitoring during the entire first three months of treatment. Comparisons between clinics demonstrated no statistically significant differences in monitoring rates. Prospective studies in academic and private practice settings are needed to provide more information on actual monitoring practices. Due to the removal of specific naufacturer recommendations, a standard approach is needed to establish consistent and adequate monitoring and to provide legal support to prescribers.

(PDF emailed within 0-6 h: $19.90)

Accession: 006963631

Download citation: RISBibTeXText

PMID: 2089823

DOI: 10.1177/106002809002401203


Related references

Compliance with recommended follow-up after fine-needle aspiration biopsy of nonpalpable breast lesions: a retrospective study. Radiology 201(1): 71-74, 1996

Prophylactic treatment uptake and compliance with recommended follow up among HIV exposed infants: a retrospective study in Addis Ababa, Ethiopia. Bmc Research Notes 4(): 563-563, 2011

Quantification of the Hawthorne effect in hand hygiene compliance monitoring using an electronic monitoring system: a retrospective cohort study. Bmj Quality & Safety 23(12): 974-980, 2016

Hematologic monitoring in children with epilepsy treated with carbamazepine. Journal of Child Neurology 4(4): 286-290, 1989

A review of carbamazepine's hematologic reactions and monitoring recommendations. Dicp 24(12): 1214-1219, 1990

Compliance to recommended liver function monitoring in patients on statin therapy. Cardiovascular Therapeutics 27(2): 96-100, 2009

Compliance with recommended self-monitoring of blood glucose in patients with Type 1 diabetes mellitus. Diabetologia 46(Supplement 2): A90, August, 2003

Compliance and adverse drug reactions: A prospective study with ethynylestradiol using continuous compliance monitoring. Clinical Investigator 71(6): 483-487, 1993

Hair Analysis for the Retrospective and Prospective Consume-Monitoring: Substance Abuse, Abstinence- and Compliance Control. Praxis 105(1): 17-21, 2016

Screening for vestibular disorders: a study of clinicians' compliance with recommended practices. Medical Science Monitor 14(5): Cr238-Cr242, 2008

Simultaneous determination of carbamazepine and carbamazepine 10,11-epoxide by using microcolumn HPLC: study of pharmacokinetics of carbamazepine in a volunteer. Biomedical Chromatography 11(1): 36-41, 1997

Long-term response to carbamazepine: a retrospective study. Journal of Clinical Psychopharmacology 8(2): 130-132, 1988

Predictors of compliance with recommended cervical cancer screening schedule: a population-based study. Journal of Community Health 24(2): 115-130, 1999

Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Annals of Clinical Biochemistry 37: 210-215, 2000